GNF Renews License to Ingenuity's Pathways Analysis Software | GenomeWeb
NEW YORK (GenomeWeb News) - Ingenuity Systems today said that the Genomics Institute of the Novartis Research Foundation has renewed and expanded a licensing agreement for its pathway analysis software.
 
The licensing deal grants GNF continued use of Ingenuity's Pathway Analysis software for the institute's research in RNA profiling, Ingenuity said. GNF originally licensed the software in 2003.
 
IPA is designed for pathway modeling and analysis in biomarker, toxicology, and pharmacogenomics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.